A serious wasting condition involving rapid muscle and fat loss due to underlying chronic disease.
Cachexia is a severe wasting syndrome characterized by rapid loss of muscle mass and body fat, often accompanied by weakness and metabolic dysfunction. It occurs as a secondary condition in chronic diseases such as cancer, HIV/AIDS, tuberculosis, or severe infections.
Cachexia differs from simple malnutrition or starvation because it involves complex metabolic alterations driven by inflammatory cytokines and tumor factors. The body experiences increased protein breakdown, decreased appetite, and altered metabolism that cannot be fully reversed by nutritional supplementation alone. This condition significantly impacts quality of life, treatment tolerance, and survival outcomes. It requires a multifaceted approach addressing both the underlying disease and nutritional support.
A pathological state that impairs physical function, reduces treatment efficacy, and increases mortality risk in patients with chronic diseases.
Work closely with oncologists or disease specialists to address the underlying condition while providing high-protein, nutrient-dense meals. Consider anti-inflammatory foods, frequent small meals, and nutritional supplements when oral intake is inadequate. Monitor weight and muscle mass regularly and adjust interventions based on individual tolerance and disease progression.
Cachexia requires a disease-specific treatment approach combining medical management of the underlying condition with targeted nutritional intervention.
A question about Cachexia? Ask our nutrition AI.
Ask a question